Vesalius Biocapital

Vesalius Biocapital related stories

All articles and analysis

• 
  Sanofi-Aventis Buying Fovea Pharma for €370 Million

  VCJ Staff- 1 October 2009

  Sanofi-Aventis has agreed to acquire Fovea Pharmaceuticals SA, a Paris, France-based drug company focused on ophthalmic diseases. The deal is valued at up to €370 million, including an upfront payment and possible milestone payments. Fovea had raised over $60 million in VC funding from firms like Forbion Capital Partners, Sofinnova Partners, Abingworth, GIMV, The Wellcome Trust and CAPE.

• 
  Apitope Raises Series A

  VCJ Staff- 23 October 2008
• 
  PE Week Wire: Thursday, October 23, 2008

  Brad Meikle- 23 October 2008

  Random Ramblings

• 
  PE Week Wire: Thursday, October 23, 2008

  Brad Meikle- 23 October 2008

  Random Ramblings

• 
  Genomic Vision Raises Series B

  PE Hub Staff- 25 July 2008
• 
  PE Week Wire: Friday, July 25, 2008

  Brad Meikle- 25 July 2008

  Random Ramblings

• 
  PE Week Wire: Friday, July 25, 2008

  Brad Meikle- 25 July 2008

  Random Ramblings